本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tscan Therapeutics, Inc.

0.2379
-0.0001-0.04%
盘后:0.23850.0006+0.25%17:27 EDT
成交量:48.35万
成交额:11.58万
市值:1,612.47万
市盈率:-0.26
高:0.2494
开:0.2400
低:0.2300
收:0.2380
52周最高:2.57
52周最低:0.2243
股本:6,777.93万
流通股本:5,436.52万
量比:0.56
换手率:0.89%
股息:- -
股息率:- -
每股收益(TTM):-0.9000
每股收益(LYR):-2.2805
净资产收益率:-95.80%
总资产收益率:-31.53%
市净率:0.23
市盈率(LYR):-0.10

数据加载中...

2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/01

重要事件披露

Form 8-K - Current report
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/17

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/10

SEC问询函

Form CORRESP - Correspondence
2024/04/10

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/08

重要事件披露

Form 8-K - Current report
2024/03/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans